Sort
23,748 grants matching “melanoma”
Processed Antigen Characterization by Mass Spectrometry
$577,016Donald F Hunt · University Of Virginia · R01 · FY2010 · AI
Advancing the translatability of mouse models for cancer immunotherapy
$576,547Rosemary J Akhurst · University Of California, San Francisco · R01 · FY2019 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$576,505Philip D Greenberg · University Of Washington · R01 · FY2016 · CA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$576,453Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$576,453Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
ITIM-receptors for cancer treatment
$576,447Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2021 · CA
Regulation of the Melanocyte Lineage by the AP2 Transcription Factor Family
$576,378Robert Aaron Cornell · University Of Iowa · R01 · FY2019 · AR
The Antigen Targeting Core
$575,890Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Non-invasive imaging of the anti-tumor immune response
$575,887Hidde L Ploegh · Boston Children'S Hospital · R01 · FY2022 · CA
Non-invasive imaging of the anti-tumor immune response
$575,887Hidde L Ploegh · Boston Children'S Hospital · R01 · FY2023 · CA
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity
$575,790Eric Meggers · Wistar Institute · P01 · FY2012 · CA
Biospecimen Unit
$575,561Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2021 · CA
Activating Native Tumor Immunity with IL-33 Armored CARs
$575,420Yina Hsing Huang · Dartmouth College · R01 · FY2025 · CA
Multimeric Ligands for Targeting of Melanoma
$575,312University Of Arizona · R01 · FY2005 · CA
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
$575,287Victor H. Engelhard · University Of Virginia · R01 · FY2009 · AI
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
$575,237Joseph C Wu · Stanford University · R01 · FY2020 · HL
Metabolic Targets in Pten-Tumors
$575,122Jeffrey A Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2013 · CA
Molecular Predictive Testing in Ocular Melanoma
$574,979James W Harbour · University Of Miami School Of Medicine · R01 · FY2020 · CA
Targeting lentiviruses to infect chosen cells
$574,827Pin Wang · University Of Southern California · R01 · FY2008 · AI
Reducing Errors in the Diagnosis of Melanoma and Melanocytic Lesions
$574,809Joann G Elmore · University Of California Los Angeles · R01 · FY2020 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$574,748Philip D Greenberg · University Of Washington · R01 · FY2017 · CA
Accuracy of In-vivo Confocal Imaging for Pigmented Lesion Diagnosis
$574,526Jay M. Eastman · Lucid, Inc. · R44 · FY2008 · CA
G alpha-q/11 Signaling and Inhibition in Ocular Melanoma
$574,451Kendall Jay Blumer · Washington University · R01 · FY2019 · CA
Comprehensive Sun Protection in Recreation: An Advanced Go Sun Smart Program
$574,433Peter Alex Andersen · San Diego State University · R01 · FY2011 · CA
3D Models of Immunotherapy
$574,412David J Mooney · Harvard University · U01 · FY2017 · CA